Literature DB >> 17531949

Functional characterization of genetic variants of human FMO3 associated with trimethylaminuria.

Catherine K Yeung1, Elinor T Adman, Allan E Rettie.   

Abstract

Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome. Numerous non-synonymous mutations in FMO3 have been identified in patients suffering from this metabolic disorder (e.g., N61S, M66I, P153L, and R492W), but the molecular mechanism(s) underlying the functional deficit attributed to these alleles has not been elucidated. The purpose of the present study was to determine the impact of these disease-associated genetic variants on FMO3 holoenzyme formation and on steady-state kinetic parameters for metabolism of several substrates, including trimethylamine. For comparative purposes, several common allelic variants not associated with primary trimethylaminuria (i.e., E158K, V257M, E308G, and the E158K/E308G haplotype) were also analyzed. When recombinantly expressed in insect cells, only the M66I and R492W mutants failed to incorporate/retain the FAD cofactor. Of the remaining mutant proteins P153L and N61S displayed substantially reduced (<10%) catalytic efficiencies for trimethylamine N-oxygenation relative to the wild-type enzyme. For N61S, reduced catalytic efficiency was solely a consequence of an increased K(m), whereas for P153L, both K(m) and k(cat) were altered. Similar results were obtained when benzydamine N-oxygenation was monitored. A homology model for FMO3 was constructed based on the crystal structure for yeast FMO which places the N61 residue alone, of the mutants analyzed here, in close proximity to the FAD catalytic center. These data demonstrate that primary trimethylaminuria is multifactorial in origin in that enzyme dysfunction can result from kinetic incompetencies as well as impaired assembly of holoprotein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531949      PMCID: PMC2039921          DOI: 10.1016/j.abb.2007.04.014

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  29 in total

1.  Mechanism of action of a flavin-containing monooxygenase.

Authors:  Subramaniam Eswaramoorthy; Jeffrey B Bonanno; Stephen K Burley; Subramanyam Swaminathan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-15       Impact factor: 11.205

Review 2.  Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.

Authors:  John R Cashman; Kathryn Camp; Steven S Fakharzadeh; Paul V Fennessey; Ronald N Hines; Orval A Mamer; Steven C Mitchell; George Preti Nguyen; Daniel Schlenk; Robert L Smith; Susan S Tjoa; David E Williams; Steven Yannicelli
Journal:  Curr Drug Metab       Date:  2003-04       Impact factor: 3.731

3.  An unusual case of trimethylaminuria.

Authors:  V Ruocco; M Florio; F G Filioli; V Guerrera; G Prota
Journal:  Br J Dermatol       Date:  1989-03       Impact factor: 9.302

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Fish odour syndrome: verification of carrier detection test.

Authors:  A Q Zhang; S Mitchell; R Smith
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Trimethylaminuria, fish odour syndrome: a new method of detection and response to treatment with metronidazole.

Authors:  E Treacy; D Johnson; J J Pitt; D M Danks
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  An assay of flavin-containing monooxygenase activity with benzydamine N-oxidation.

Authors:  A Kawaji; K Ohara; E Takabatake
Journal:  Anal Biochem       Date:  1993-11-01       Impact factor: 3.365

8.  The identification of trimethylamine excess in man: quantitative analysis and biochemical origins.

Authors:  S Tjoa; P Fennessey
Journal:  Anal Biochem       Date:  1991-08-15       Impact factor: 3.365

Review 9.  Trimethylaminuria and a human FMO3 mutation database.

Authors:  Diana Hernandez; Sarah Addou; David Lee; Christine Orengo; Elizabeth A Shephard; Ian R Phillips
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

10.  The N-oxidation of trimethylamine in a Jordanian population.

Authors:  H F Hadidi; S Cholerton; S Atkinson; Y M Irshaid; N M Rawashdeh; J R Idle
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

View more
  22 in total

1.  Molecular phylogeny, long-term evolution, and functional divergence of flavin-containing monooxygenases.

Authors:  Da Cheng Hao; Shi Lin Chen; Jun Mu; Pei Gen Xiao
Journal:  Genetica       Date:  2009-07-05       Impact factor: 1.082

2.  Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver.

Authors:  Trine Celius; Andrea Pansoy; Jason Matthews; Allan B Okey; Marilyn C Henderson; Sharon K Krueger; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-04       Impact factor: 4.219

3.  Characterization of human flavin-containing monooxygenase (FMO) 3 and FMO5 expressed as maltose-binding protein fusions.

Authors:  Robert R Reddy; Erik C Ralph; Meike S Motika; Jun Zhang; John R Cashman
Journal:  Drug Metab Dispos       Date:  2010-09-01       Impact factor: 3.922

4.  Molecular cloning, sequence characterization, SNP detection, and tissue expression analysis of duck FMO3 gene.

Authors:  Peng Wang; Jiangxia Zheng; Lujiang Qu; Ling Lian; Guiyun Xu; Ning Yang
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

5.  Trimethylaminuria: causes and diagnosis of a socially distressing condition.

Authors:  Richard J Mackay; Christopher J McEntyre; Caroline Henderson; Michael Lever; Peter M George
Journal:  Clin Biochem Rev       Date:  2011-02

6.  Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver.

Authors:  Trine Celius; Steven Roblin; Patricia A Harper; Jason Matthews; Paul C Boutros; Raimo Pohjanvirta; Allan B Okey
Journal:  Drug Metab Dispos       Date:  2008-09-02       Impact factor: 3.922

7.  Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease.

Authors:  Kong-Xiang Zhu; Pei-Yuan Song; Mu-Peng Li; Yin-Xiao Du; Qi-Lin Ma; Li-Ming Peng; Xiao-Ping Chen
Journal:  Eur J Clin Pharmacol       Date:  2020-10-21       Impact factor: 2.953

8.  Inter-individual variation in flavin-containing monooxygenase 3 in livers from Japanese: correlation with hepatic transcription factors.

Authors:  Satomi Nagashima; Makiko Shimizu; Hiroshi Yano; Norie Murayama; Toshio Kumai; Shinichi Kobayashi; F Peter Guengerich; Hiroshi Yamazaki
Journal:  Drug Metab Pharmacokinet       Date:  2009       Impact factor: 3.614

9.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.

Authors:  Sharon K Krueger; Marilyn C Henderson; Lisbeth K Siddens; Jonathan E VanDyke; Abby D Benninghoff; P Andrew Karplus; Bjarte Furnes; Daniel Schlenk; David E Williams
Journal:  Drug Metab Dispos       Date:  2009-05-06       Impact factor: 3.922

10.  Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.

Authors:  Meike S Motika; Jun Zhang; Xueying Zheng; Kiersten Riedler; John R Cashman
Journal:  Mol Genet Metab       Date:  2009-02-27       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.